Clinical Trial Results: Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydroxychloroquine as Treatment in Untreated Pancreas Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating paclitaxel protein-bound plus gemcitabine, cisplatin, and hydroxychloroquine as treatment for untreated pancreatic adenocarcin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Hydroxychloroquine (hydroxychloroquine)
• Paclitaxel protein-bound (paclitaxel protein-bound)

Snippet

Sponsor: HonorHealth Research Institute | Conditions: Untreated Resectable Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2026-07-21